Transient hypertransaminasemia in pediatric patients with crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 2, 2011, Pages 229-

  Lemberg, D A ^a   Leach, S T ^b   Day, A S ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CROHN DISEASE; ENTERIC FEEDING; HUMAN; HYPERTRANSAMINASEMIA; LETTER; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; HUMANS; MALE;

EID: 79961189217     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31821c6497     Document Type: Letter

References (2)

1. Schatorjé E, Hoekstra H. Transient hypertransaminasemia in pediatric patients with Crohn disease undergoing initial treatment with enteral nutrition. J Pediatr Gastroenterol Nutr 2010;51:336-40.
2. Day AS, Whitten KE, Lemberg DA, et al. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol 2006; 21:1609-14. (Pubitemid 44266523)